Emily L. Germain‐Lee

Author

Also Known As

E L Germain-Lee, E.L. Germain-Lee, EMILY GERMAIN-LEE, EMILY GERMAIN‐LEE, EMILY L. GERMAIN, EMILY L. GERMAIN-LEE, EMILY L. GERMAIN‐LEE, Emily Germain-Lee, Emily L Germain, Emily L Germain-Lee

Publications

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Kennedy Krieger Institute University of Connecticut Jackson Laboratory

About

Emily L. Germain‐Lee is an author at Johns Hopkins University specializing in medicine, physiology, and endocrinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	21	1.2K
2	Health Sciences	7	7	346
3	Engineering	1	1	22
4	Allergy	1	1	16
5	Biochemistry	1	1	21

Emily L. Germain‐Lee

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders Bernadette E. Reuber, Emily L. Germain‐Lee, Cynthia S. Collins, Nature Genetics Peroxisome Biogenesis DisordersMendelian DisorderGenetic DisorderGeneticsMolecular Genetics	1997	234
Body Mass Index Differences in Pseudohypoparathyroidism Type 1a<i>Versus</i>Pseudopseudohypoparathyroidism May Implicate Paternal Imprinting of Gαs in the Development of Human Obesity Dominique Long, Sarah McGuire, Michael A. Levine, The Journal of Clinical Endocrinology & Metabolism	2006	181
Growth Hormone Deficiency in Pseudohypoparathyroidism Type 1a: Another Manifestation of Multihormone Resistance Emily L. Germain‐Lee, Joshua D. Groman, Janet L. Crane, The Journal of Clinical Endocrinology & Metabolism Php Type 1AHuman GrowthGeneticsType 1AOsteoporosis	2003	157
Paternal imprinting of Gαs in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a Emily L. Germain‐Lee, Chang-Lin Ding, Zhi‐chao Deng, Biochemical and Biophysical Research Communications Human ThyroidTsh ResistancePaternal ImprintingGeneticsThyroid Disease	2002	145
A Mouse Model of Albright Hereditary Osteodystrophy Generated by Targeted Disruption of Exon 1 of the Gnas Gene Emily L. Germain‐Lee, William F. Schwindinger, Janet L. Crane, Endocrinology	2005	127
Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight Se‐Jin Lee, Adam Lehar, Jessica U. Meir, Proceedings of the National Academy of Sciences	2020	109
Expression of a type I insulin-like growth factor receptor with low affinity for insulin-like growth factor II Emily L. Germain‐Lee, Michel Janicot, Reiner Lammers, Biochemical Journal Human GrowthImmunologyInsulin SignalingBinding PropertiesMetabolic Syndrome	1992	68
Age‐related Anti‐thyroid Antibodies and Thyroid Abnormalities in Turner Syndrome Emily L. Germain‐Lee, Leslie Plotnick Acta Paediatrica	1986	68
Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass Brian C. Goh, Vandana Singhal, Angelica J. Herrera, Journal of Biological Chemistry	2017	63
Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A Se‐Jin Lee, Adam Lehar, Yewei Liu, Proceedings of the National Academy of Sciences Skeletal Muscle GrowthMuscle FunctionHuman GrowthImmunologyCytoskeleton	2020	56

Page 1